Special Issue Reviews–A Peer Reviewed Forum
Interactions between SOX factors and Wnt/β-catenin signaling in development and disease
Article first published online: 4 AUG 2009
Copyright © 2009 Wiley-Liss, Inc.
Special Issue: Special Issue on WNT Signaling in Development and Disease
Volume 239, Issue 1, pages 56–68, January 2010
How to Cite
Kormish, J. D., Sinner, D. and Zorn, A. M. (2010), Interactions between SOX factors and Wnt/β-catenin signaling in development and disease. Dev. Dyn., 239: 56–68. doi: 10.1002/dvdy.22046
- Issue published online: 15 DEC 2009
- Article first published online: 4 AUG 2009
- Manuscript Accepted: 24 JUN 2009
- NIH. Grant Numbers: HD42572, DK70858, T32 HD046387
- 2006. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 66: 3434–3442. , , , , , , , , .
- 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813–2828. , , , , .
- 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18: 1072–1087. , , , , , , , , , , , .
- 2005. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol 23: 499–505. , , , , , , , .
- 2009. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 100: 511–523. , , , , , , , , , , .
- 2005. SoxB1 downregulation in vegetal lineages of sea urchin embryos is achieved by both transcriptional repression and selective protein turnover. Development 132: 999–1008. , , .
- 2007. Mutual antagonism of SoxB1 and canonical Wnt signaling in sea urchin embryos. Signal Transduciton 7: 174–180. , , , .
- 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25: 7492–7504. , , .
- 2007. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178: 635–648. , , , , , , , , , , , .
- 2008. Human SRY inhibits beta-catenin-mediated transcription. Int J Biochem Cell Biol 40: 2889–2900. , , , , .
- 1999. Sox9 is required for cartilage formation. Nat Genet 22: 85–89. , , , , .
- 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98: 6698–6703. , , , , , , .
- 2004. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 166: 37–47. , , , , , , , .
- 2000. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227: 239–255. , , .
- 1999. XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development 126: 3159–3170. , , , , .
- 2002. Formation of neuroblasts in the embryonic central nervous system of Drosophila melanogaster is controlled by SoxNeuro. Development 129: 4193–4203. , , .
- 2006. Wnt signaling: complexity at the surface. J Cell Sci 119: 395–402. , .
- 2007. The HMG-box transcription factor SoxNeuro acts with Tcf to control Wg/Wnt signaling activity. Development 134: 989–997. , , .
- 2008. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum Mol Genet 17: 1264–1277. , , , , , , , , .
- 2008. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969–17978. , , , , , , , , , , .
- 2002. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297: 365–369. , .
- 2004. Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 18: 2418–2429. , , , , , , , , , , , , , .
- 2008. Wnt signaling in cartilage development and degeneration. BMB Rep 41: 485–494. , , , .
- 2002. Sex with two SOX on: SRY and SOX9 in testis development. Trends Endocrinol Metab 13: 106–111. , .
- 2006. Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480. .
- 2002. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol Cell 10: 573–584. , .
- 2005. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12: 364–371. , .
- 2008. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 10: 648–660. , , , , , , , .
- 2009. SoxF is part of a novel negative-feedback loop in the wingless pathway that controls proliferation in the Drosophila wing disc. Development 136: 761–769. , , .
- 2004. Sox genes and cancer. Cytogenet Genome Res 105: 442–447. , , .
- 2009. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat , , , , , , .
- 2005. Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 280: 35203–35208. , , , , , , , .
- 2002. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc Natl Acad Sci U S A 99: 11199–11204. , , , , , , .
- 2005. SUMO changes Sox for developmental diversity. Mol Cell 20: 495–496. .
- 2006. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429–22433. , .
- 2008. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 6: 1421–1430. , , , , , , , , , , , .
- 2008. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Prostate 68: 1517–1530. , , , , , , , , , , .
- 1994. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22: 1500–1501. , , .
- 2006. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 281: 14417–14428. , , , , , , , .
- 2006. Patterning the early Xenopus embryo. Development 133: 1205–1217. .
- 2007. Wnt signalling: variety at the core. J Cell Sci 120: 385–393. , .
- 1997. Xsox17alpha and -beta mediate endoderm formation in Xenopus. Cell 91: 397–405. , , , , .
- 2002. Involvement of NLK and Sox11 in neural induction in Xenopus development. Genes Cells 7: 487–496. , , , , , .
- 2007. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem 282: 19052–19061. , , , , , , , , , .
- 2005. Wnt signaling: multiple functions in neural development. Cell Mol Life Sci 62: 1100–1108. , .
- 1998. Involvement of Sox1, 2 and 3 in the early and subsequent molecular events of lens induction. Development 125: 2521–2532. , , , , .
- 2000. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16: 182–187. , , .
- 2004. Sox1 acts through multiple independent pathways to promote neurogenesis. Dev Biol 269: 580–594. , , , , , , , .
- 1999. SpSoxB1, a maternally encoded transcription factor asymmetrically distributed among early sea urchin blastomeres. Development 126: 5473–5483. , , , , .
- 2003. Tight regulation of SpSoxB factors is required for patterning and morphogenesis in sea urchin embryos. Dev Biol 261: 412–425. , , , , .
- 2007. Back to basics: Sox genes. Dev Dyn 236: 2356–2366. .
- 2006. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482–7491. , .
- 1991. Male development of chromosomally female mice transgenic for Sry. Nature 351: 117–121. , , , , .
- 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC −/− colon carcinoma. Science 275: 1784–1787. , , , , , , , .
- 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336–2346. , , , , .
- 2006. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66: 4011–4019. , , , , , , , , , , .
- 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810. , .
- 2008. Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 17: 2949–2955. , , , , , .
- 2005. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 168: 1065–1076. , , , , .
- 2009. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 18: 1343–1352. , , , , , , , , , , , , .
- 2007. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 315: 230–233. , , , , , , , , .
- 1999. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res 27: 1359–1364. , , .
- 2007. SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 133: 539–546. , , , , , , , .
- 1996. The Drosophila fish-hook gene encodes a HMG domain protein essential for segmentation and CNS development. Development 122: 3467–3475. , .
- 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183: 108–121. , , , , , , , , , .
- 2006. Sox2 is required for development of taste bud sensory cells. Genes Dev 20: 2654–2659. , , .
- 2008. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 98: 824–831. , , , .
- 2007. The Drosophila HMG-domain proteins SoxNeuro and Dichaete direct trichome formation via the activation of shavenbaby and the restriction of Wingless pathway activity. Development 134: 2807–2813. , , .
- 2002. Evidence for differential and redundant function of the Sox genes Dichaete and SoxN during CNS development in Drosophila. Development 129: 4219–4228. , , , .
- 2006. Ubc9 interacts with SOX4 and represses its transcriptional activity. Biochem Biophys Res Commun 344: 727–734. , , , , , , , , , , , , .
- 2009. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 106: 3788–3793. , , , , , , , , , , , , .
- 2005. SOX genes and neural progenitor identity. Curr Opin Neurobiol 15: 7–13. , .
- 2007. Sry and the hesitant beginnings of male development. Dev Biol 302: 13–24. , .
- 2001. Compound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation. J Biol Chem 276: 27864–27872. , , , , , , , , , .
- 2002. Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol 22: 5826–5834. , , , , , .
- 2005. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res 65: 166–176. , , , , , , , .
- 1998. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395: 608–612. , , , , , , , , .
- 1996. The Dichaete gene of Drosophila melanogaster encodes a SOX-domain protein required for embryonic segmentation. Development 122: 3669–3676. , , , .
- 2007. A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18. Biochem Biophys Res Commun 360: 370–374. , , , , .
- 2005. SUMO represses transcriptional activity of the Drosophila SoxNeuro and human Sox3 central nervous system-specific transcription factors. Mol Biol Cell 16: 2660–2669. , , .
- 2001. Spatially precise DNA bending is an essential activity of the sox2 transcription factor. J Biol Chem 276: 47296–47302. , .
- 2009. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 69: 709–717. , , , , , .
- 2007. SnapShot: noncanonical Wnt signaling pathways. Cell 131: 1378. , , , .
- 2004. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 131: 3069–3080. , , , .
- 2006. Global analysis of the transcriptional network controlling Xenopus endoderm formation. Development 133: 1955–1966. , , , , , , , , .
- 2007. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27: 7802–7815. , , , , , , , , .
- 2004. The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease. Trends Genet 20: 4–8. , .
- 2006. Transcription under the control of nuclear Arm/beta-catenin. Curr Biol 16: R378–385. , , .
- 2001. SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29: 4274–4283. , , , , , , .
- 2006. Convergence of Wnt and FGF signals in the genesis of posterior neural plate through activation of the Sox2 enhancer N-1. Development 133: 297–306. , , , .
- 2008. Ectopic expression of mouse Sry interferes with Wnt/beta-catenin signaling in mouse embryonal carcinoma cell lines. Biochim Biophys Acta 1780: 1395–1402. , , .
- 2005. SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation. Dev Cell 9: 593–603. , .
- 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426. , .
- 2008. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet 17: 1278–1291. , , , , , , , , , , , .
- 2009. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 284: 3323–3333. , , , , .
- 2003. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278: 27224–27229. , , , .
- 2000. Sequence-specific high mobility group box factors recognize 10-12-base pair minor groove motifs. J Biol Chem 275: 27266–27273. , , , , , , .
- 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in an SRY related gene SOX9. Cell 79: 1111–1120. , , , , , , , , , , , , , .
- 2006. Sox3 expression identifies neural progenitors in persistent neonatal and adult mouse forebrain germinative zones. J Comp Neurol 497: 88–100. , , , , , .
- 2003. Identification of novel domains within Sox-2 and Sox-11 involved in autoinhibition of DNA binding and partnership specificity. J Biol Chem 278: 17901–17911. , , .
- 2002. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12: 441–446. , .
- 2006. The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res 34: 1735–1744. , , , , .
- 2007. Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci 120: 3337–3344. , .
- 2003. The beta-catenin/VegT-regulated early zygotic gene Xnr5 is a direct target of SOX3 regulation. Development 130: 5609–5624. , , , .
- 2008. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 68: 2764–2772. , , , , , , , , , , , .
- 2009. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277: 29–37. , , , , , , , , , , , .
- 1999. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4: 487–498. , , , , , .